ICER finds new drug prices surged from 2022 to 2025
Median net prices for newly launched medicines increased to $257,000 from $173,000 between 2022 and 2025, with most exceeding cost-effectiveness thresholds.
Palanor Wire · composed from 3 outlets · every claim links to its sources
What happened
Median list prices of drugs at launch rose 24% from 2022 to 2025, while median net prices rose 35% over the same period. 134 The median net price for 202 newly launched medicines increased to $257,000 last year from $173,000 in 2022. 4 The analysis comes from a new report by the Institute for Clinical and Economic Review, a non-profit group. 12 The majority of new drugs launched were well above ICER's cost-effectiveness guidelines. 2 Launch prices dipped slightly last year but remained high, according to the analysis. 4
Why it matters
ICER found most new medicines are still too costly at launch relative to their therapeutic value. 2 The report suggests drug launch prices are outpacing their worth, with net prices exceeding list price increases. 12
What to watch
Watch for whether ICER's findings prompt scrutiny of manufacturer discounts and inflation adjustments. 1 Monitor whether pharmaceutical companies align future launch prices more closely with cost-effectiveness guidelines. 2
Sources · 4
[1]STAT+: Pharmalittle: We’re reading about drug launch prices, an AstraZeneca AI deal, and more
STAT
[2]Most new drugs are still too costly at launch, ICER says
BioPharma Dive
[3]STAT+: Launch prices for new medicines dipped slightly last year but remain high, analysis finds
STAT
[4]New ICER report suggests drug launch prices are outpacing their worth
Endpoints News
Matched signals
Lattice signals Numen pinned to this story at publish time.
No matched signals on this story.
Unlock the analytical widgets on every article — signal matches, Trends snapshots, X overlays, agent reasoning — with a Member account.
Upgrade →On X right now
Top engagement posts about this topic, ranked by likes + retweets + quotes.
No high-engagement X posts captured for this topic. Either the topic is too quiet or the upstream API was unavailable when this article published.
Unlock the analytical widgets on every article — signal matches, Trends snapshots, X overlays, agent reasoning — with a Member account.
Upgrade →Your read
How did this article land?
Three sliders. Optional comment. Anonymous is fine.
Open to anyone. One response per reader.